GSK Plc ADR
GSK Plc ADR (GSK) Wheel Strategy
GSK wheel strategy scan found 66 cash-secured put setups on the previous trading day. Probability of expiring worthless is above 50%. Annualized returns reach up to 50.5%.
Read more
Running a GSK wheel strategy lets you generate consistent premium income on GSK Plc ADR while setting your own entry and exit prices on the underlying. GSK Plc ADR's wheel combines cash-secured puts and covered calls into a repeatable cycle: sell puts at strikes where you'd be happy to own GSK, and if assigned, sell calls at strikes where you'd be happy to sell. Use our scanner to find the best GSK wheel strategy setups in real time.
The wheel works best on liquid, high-quality names with stable fundamentals and active options markets — exactly the profile many large-cap leaders fit. The mechanics are simple: sell a cash-secured put on GSK, collect premium, and either keep the premium if it expires worthless or take assignment at a discount to current price. Once assigned, sell covered calls against the shares to keep collecting premium until they're called away. Choosing the right strikes, expirations, and IV environment is what separates a profitable GSK wheel from a losing one.
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections.
It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development; two strategic collaborations with Relation to advance therapeutics for fibrotic diseases and osteoarthritis; and multi-target strategic alliance with GSK to develop breakthrough treatments for people afflicted with Parkinson's disease; as well as collaboration with Flagship Pioneering to discover novel medicines and vaccines. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.dom.
The difference between a wheel that compounds and one that bleeds comes down to strike selection, IV timing, and discipline on assignment. Our scanner handles the heavy lifting: it ranks every leg of the GSK wheel strategy by delta, premium yield, IV rank, and days to expiration, so you can deploy capital where the math works. Build your GSK wheel strategy on data, not gut feel — and let the options wheel do what it does best: pay you to wait.
| Oct 2, 2026 | 49.00 | $0.25 | $0.48 | -0.42 | 7 | 17% | 55.9% | 50.5% | 121 |
| Oct 16, 2026 | 49.00 | $0.85 | $0.95 | -0.44 | 21 | 17% | 53.6% | 33.7% | 73 |
| Oct 2, 2026 | 47.00 | $0.05 | $0.30 | -0.19 | 7 | 17% | 91.6% | 33.3% | 17 |
| Oct 30, 2026 | 49.00 | $1.30 | $1.48 | -0.44 | 35 | 17% | 53.0% | 31.4% | 4 |
| Oct 9, 2026 | 49.00 | $0.20 | $0.58 | -0.42 | 14 | 17% | 54.3% | 30.6% | 7 |
| Oct 2, 2026 | 48.50 | $0.20 | $0.28 | -0.29 | 7 | 17% | 67.4% | 29.6% | 9 |
| Oct 23, 2026 | 49.00 | $0.75 | $1.08 | -0.44 | 28 | 17% | 53.2% | 28.6% | 0 |
| Oct 9, 2026 | 48.50 | $0.30 | $0.53 | -0.35 | 14 | 17% | 62.5% | 28.2% | 0 |
| Oct 16, 2026 | 48.50 | $0.65 | $0.73 | -0.37 | 21 | 17% | 60.4% | 26.0% | 22 |
| Nov 6, 2026 | 49.00 | $0.80 | $1.45 | -0.44 | 42 | 17% | 52.8% | 25.7% | 0 |
As of September 29, 2026
Run the Wheel on GSK With Confidence
Find the best GSK wheel strategy setups across strikes and expirations, plan ahead with at-strike values, and keep your covered calls and puts on track.
Start your 14-day free trial→